Reply
sales@sdp.org.in
We are delighted to introduce our large range of Active Pharmaceutical Ingredients (APIs) and Excipients. we Supply all our products to meet international standards (IP/BP/EP/USP/JP) and support your formulation needs with high quality and reliability with regulatory documents requirements such as GMP, Drug Licence, DMF, CEP, WC etc.
Mr Amol Patil
Manager- Sales and Marketing Dept.
SWAPNROOP DRUGS AND PHARMACEUTICALS
E-mail: sales@sdp.org.in Website:- www.sdp.org.in
hostrinlifesciences@gmail.com
Hostrin Life Sciences
*One Stop For Pharmaceutical and Biosimilar Regulatory Solutions.
Hostrin offers the following services:
1.In and out licensing Dossiers
2.Dossiers in CTD/ACTD/eCTD formats with e-softwares.
3.BE & Clinical studies Studies
4.CDMO (Contract Research & Development)
5.Tech transfer support and registration of dossiers in all markets.
6.Computer System Validations (CSV) as per GAMP 5 Guidelines, PLC/SCADA/HMI Validation, and Documentation.
7.QBD & QMS_Quality Management Systems: GXP/GMP Advisory & EU-GMP/UK-MHRA/TGA/PMDA/WHO-GMP/PICS and USFDA_21_CFR with all GAP Assessment Audits
Pls visit our website www.hostringlobal.com
Best Regards,
Andrew P
CEO & Managing Director
Hostrin Life sciences
hostrinlifesciences@gmail.com
Mobile/
WhatsApp: +919949930343
Cristonelifecare@gmail.com
Cristone Life Care is globally connected, offering efficient quality products from EU-GMP, UK-MHRA, USFDA, PICS, and WHO-GMP approved facilities as follows:
* Pharmaceutical and Biosimilar APIs, and finished formulations.
* Oncology Exclusivity
* Antibody Drug Conjugates.
* Nutraceutical/Food Suppliments
* Critical Care and Life Savings drugs.
* Impurity's and RLD's
* Vaccines
For export orders,
connect with us at www.cristoneglobal.com. Send your inquiries to cristonelifecare@gmail.com; marketing@cristoneglobal.com. #Pharmaceuticals #Biosimilars #ExportOrders
lazycircuit99@gmail.com
Pharma professionals: join our Telegram network to collaborate, exchange insights and grow together — join here ???? https://t.me/+R3UhZ8KR9L0wZWNl
